Evvy

New York, United States Founded: 2002 • Age: 24 yrs
Vaginal microbiome test kits are provided through an online platform.
Request Access

About Evvy

Evvy is a company based in New York (United States) founded in 2002 by Priyanka Jain.. Evvy has raised $19 million across 2 funding rounds from investors including LabCorp, Left Lane Capital and General Catalyst. The company has 9 employees as of December 31, 2023. Evvy offers products and services including Vaginal Health Test, Anti-Itch Vulva Cream, Hyaluronic Acid Suppositories, and Pure Boric Acid Suppositories. Evvy operates in a competitive market with competitors including Viome, Flore, uBiome, Jona and Kean Health, among others.

  • Headquarter New York, United States
  • Employees 9 as on 31 Dec, 2023
  • Founders Priyanka Jain
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $19 M (USD)

    in 2 rounds

  • Latest Funding Round
    $14 M (USD), Series A

    Sep 27, 2023

  • Investors
    LabCorp

    & 10 more

  • Employee Count
    9

    as on Dec 31, 2023

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Evvy

Evvy offers a comprehensive portfolio of products and services, including Vaginal Health Test, Anti-Itch Vulva Cream, Hyaluronic Acid Suppositories, and Pure Boric Acid Suppositories. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

At-home swab for analyzing vaginal microbiome and health outcomes.

Cream to soothe and relieve vulva irritation and discomfort.

Suppositories for maintaining vaginal moisture and health balance.

Suppositories to address imbalances in the vaginal microbiome.

People of Evvy
Headcount 10-50
Employee Profiles 16
Board Members and Advisors 8
Employee Profiles
People
Kwame Thomison
Chief Technology Officer
People
Priyanka Jain
CEO & Co-Founder
People
Laine Bruzek
Chief Marketing Officer & Co-Founder
People
Pita Navarro
Co-Founder & Chief Science Officer

Unlock access to complete

Board Members and Advisors
people
Diana Currie
Advisor
people
Jill Krapf
Advisor
people
Margo Georgiadis
Advisor
people
Momo Vuyisich
Advisor

Unlock access to complete

Funding Insights of Evvy

Evvy has successfully raised a total of $19M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $14 million completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series A — $14.0M
  • First Round

    (14 Jun 2021)

  • Investors Count 11
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2023 Amount Series A - Evvy Valuation Left Lane
Jun, 2021 Amount Seed - Evvy Valuation General Catalyst , BoxGroup
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Evvy

Evvy has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include LabCorp, Left Lane Capital and General Catalyst. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investments are directed toward high-growth consumer and internet technology companies.
Founded Year Domain Location
Investment and transformation services for entrepreneurs in technology and finance sectors.
Founded Year Domain Location
Investments are focused on reproductive healthcare startups by Rhia Ventures.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Evvy

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Evvy

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Evvy Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Evvy

Evvy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viome, Flore, uBiome, Jona and Kean Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Machine learning-based bioinformatics solutions for health insights are provided.
domain founded_year HQ Location
Customized probiotics for gut health are provided via stool analysis.
domain founded_year HQ Location
Provides comprehensive sequence datasets for human microbiome research and analysis.
domain founded_year HQ Location
AI-powered microbiome profiling platform to improve digestive health
domain founded_year HQ Location
At-home kits for gut microbiome, gene, and vaginal health testing services.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Evvy

Frequently Asked Questions about Evvy

When was Evvy founded?

Evvy was founded in 2002 and raised its 1st funding round 19 years after it was founded.

Where is Evvy located?

Evvy is headquartered in New York, United States. It is registered at New York, New York, United States.

Who is the current CEO of Evvy?

Priyanka Jain is the current CEO of Evvy. They have also founded this company.

Is Evvy a funded company?

Evvy is a funded company, having raised a total of $19M across 2 funding rounds to date. The company's 1st funding round was a Seed of $5M, raised on Jun 14, 2021.

How many employees does Evvy have?

As of Dec 31, 2023, the latest employee count at Evvy is 9.

What does Evvy do?

Evvy was founded in 2002 in New York, United States, within the health technology sector. An online platform is maintained to distribute at-home test kits focused on vaginal microbiome analysis. Services include sample collection kits and diagnostic reporting, with operations centered in the U.S. to support womens health monitoring. The company is led by co-founder and CEO Priyanka Jain.

Who are the top competitors of Evvy?

Evvy's top competitors include Viome, Flore and HyperSpectral.

What products or services does Evvy offer?

Evvy offers Vaginal Health Test, Anti-Itch Vulva Cream, Hyaluronic Acid Suppositories, and Pure Boric Acid Suppositories.

Who are Evvy's investors?

Evvy has 11 investors. Key investors include LabCorp, Left Lane Capital, General Catalyst, Rhia Ventures, and Ingeborg Investments.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available